Tiny pulses of electricity may provide the next big advance in treating diseases like rheumatoid arthritis. The pulses would ...

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

"Access to this information is crucial for infectious diseases and HIV health care professionals who care for people with HIV ...

Nearly 1,300 employees at the Centers for Disease Control and Prevention are being forced out under the Trump administration’s move to get rid of all probationary employees. That's roughly one-tenth ...

In an interview with Game Rant, Avowed developers discuss the story's central themes and recreating the world of Eora in a ...

At dawn, 65-year-old Nelly Mutandwa swapped her pajamas for leggings, a T-shirt and sneakers. She grabbed a bottle of water before heading to an unconventional workout ...

Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...

A: As dry as you can get it so that burning it won’t gum up your chimney with flammable creosote. How to tell? One indicator ...

The FDA accepts and grants priority review to INSM's NDA for brensocatib to treat patients with non-cystic fibrosis bronchiectasis. A decision is due on Aug. 12, 2025.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The world's largest living organism is slowing being eaten alive after living on Earth for thousands of years. The Pando is a ...